BRAINBox Solutions, a spinout from ImmunArray USA, is developing a series of products and multiplex tests to assist in the diagnosis and prognosis of Traumatic Brain Injury (“TBI”). Builds on a completed 550 patient longitudinal study done over a two-year period and the broadest portfolio of biomarkers in the field
Series A financing led by BioVentures
Provide physicians with objective information to identify and assess severity of suspected TBI from an acute event, monitoring and "return to play" tests will be used during treatment plans
If you would like to learn more information about this transaction contact us below.